Decoding the tumor microenvironment of triple-negative breast cancer: from immune evasion to precision immunotherapy
Triple-negative breast cancer (TNBC) represents a highly aggressive breast cancer subtype characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, resulting in limited targeted therapeutic options and poor clinical…